Link to this page
Biological and Environmental Research Ontology
| Id | http://purl.obolibrary.org/obo/NCIT_C71132
http://purl.obolibrary.org/obo/NCIT_C71132
|
|---|---|
| Preferred Name | Oral Microencapsulated Diindolylmethane |
| Definitions |
An orally bioavailable microencapsulated formulation of diindolylmethane, an indole phytonutrient found in cruciferous vegetables, with estrogen-modulating, antiandrogenic, and potential antineoplastic activities. As a dimer of indole-3-carbinol, diindolylmethane (DIM) modulates estrogen balance by reducing the levels of 16-hydroxy estrogen metabolites and increasing the formation of beneficial 2-hydroxy estrogen metabolites. DIM also antagonizes androgen receptor activity, which may result in diminished cell proliferation and apoptosis in susceptible tumor cell populations. Pure DIM, which is relatively hydrophobic, is poorly absorbed after oral administration. This oral formulation, which consists of DIM, d-alpha-tocopheryl acid succinate, phosphatidylcholine, and silica microencapsulated in starch, significantly improves the gastrointestinal absorption of DIM.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally bioavailable microencapsulated formulation of diindolylmethane, an indole phytonutrient found in cruciferous vegetables, with estrogen-modulating, antiandrogenic, and potential antineoplastic activities. As a dimer of indole-3-carbinol, diindolylmethane (DIM) modulates estrogen balance by reducing the levels of 16-hydroxy estrogen metabolites and increasing the formation of beneficial 2-hydroxy estrogen metabolites. DIM also antagonizes androgen receptor activity, which may result in diminished cell proliferation and apoptosis in susceptible tumor cell populations. Pure DIM, which is relatively hydrophobic, is poorly absorbed after oral administration. This oral formulation, which consists of DIM, d-alpha-tocopheryl acid succinate, phosphatidylcholine, and silica microencapsulated in starch, significantly improves the gastrointestinal absorption of DIM. |
|---|---|
| prefLabel | Oral Microencapsulated Diindolylmethane
|
| label | Oral Microencapsulated Diindolylmethane
|
| NCI_META_CUI | CL377701
|
| PDQ_Closed_Trial_Search_ID | 577331
|
| code | C71132
|
| prefixIRI | NCIT:C71132
|
| in_subset |
See more
See less
|
| Display_Name | Oral Microencapsulated Diindolylmethane
|
| Preferred_Name | Oral Microencapsulated Diindolylmethane
|
| Contributing_Source | CTRP
|
| Maps_To | Oral Microencapsulated Diindolylmethane
|
| NCI_Drug_Dictionary_ID | 577331
|
| Legacy Concept Name | Oral_Microencapsulated_Diindolylmethane
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 577331
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |